EN
HI
Biogen Pharmachem Industries Chart
Biogen Pharmachem Industries Share Key Metrics
Volume
9.61 L
Market Cap
47.84 CR
LTQ@LTP
3@0.53
ATP
0.52
Var Margin
25 %
Circuit Range
0.43-0.63
Delivery %
66.49 %
Value
5.00 L
ASM/GSM
No
Market Lot
1
Summary
At 24 Mar, 2026 | 14:33, Biogen Pharmachem Industries share price stands at ₹0.53, showing a 0.00% 0.00 for the day. The stock’s intraday movement has stayed between ₹0.52 and ₹0.53, while on a 52-week basis it has fluctuated from ₹0.50 to ₹1.08.
In terms of trading activity, Biogen Pharmachem Industries has recorded a volume of 961023 shares, with a market capitalisation of ₹902603000. The stock’s Average Traded Price (ATP) stands at ₹52, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3,53. The stock operates within a circuit range of ₹0.43-0.63, with a Value of ₹5.00 L. The Delivery Percentage for the day is 66.49%. Additionally, Biogen Pharmachem Industries currently falls under the No framework, and trades with a market lot size of 1.
Biogen Pharmachem Industries Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
37.56
Sector P/B
1.89
Sec. Div. Yield
82.62
Biogen Pharmachem Industries Resistance and Support
Pivot 0.53
Resistance
First Resistance
0.55
Second Resistance
0.58
Third Resistance
0.6
Support
First Support
0.5
Second Support
0.48
Third Support
0.45
Biogen Pharmachem Industries Corporate Actions
| Date | Agenda |
|---|---|
| 2026-03-23 | Bonus issue |
| 2026-02-11 | Quarterly Results |
| 2026-02-03 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-07-23 | Quarterly Results |
| 2025-05-23 | Audited Results |
| 2025-02-05 | Quarterly Results & Others |
Biogen Pharmachem Industries News
Biogen Pharmachem Industries Ltd - 531752 - Regulations 30 Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Board Recommends The Issuance Of Fully Paid-Up Bonus Shares In The Ratio Of 1:6.
Biogen Pharmachem's board recommended a 1:6 bonus share issue and approved increasing authorized share capital from ₹91 crore to ₹108 crore. The new bonus shares will be credited within two months and are subject to shareholder approval via postal ballot.
Mar 23 2026 19:03:00
Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 23Rd March 2026
Biogen's board approved a 1:6 bonus share issue and increased the authorized share capital from ₹91 crores to ₹108 crores. This move aims to enhance shareholder value and strengthen the company's capital structure, subject to shareholder approval via postal ballot within two months.
Mar 23 2026 19:03:00
Read More
About Biogen Pharmachem Industries
NSE : 0
BSE : 531752
ISIN : INE703D01023
Biogen Pharmachem Industries Management
| Name | Position |
|---|---|
| Mr. Kelash Bunkar | WholeTime Director & CFO |
| Mr. Chandrakant Govindbhai Parmar | Director |
Biogen Pharmachem Industries Similar Stocks
Krishna Ventures Ltd.
20.00
-0.50 (2.44%)
Surat Trade and Mercantile Ltd.
3.88
0.17 (4.58%)
Lykis Ltd.
45.90
0.36 (0.79%)
Goyal Aluminiums Ltd.
5.89
0.20 (3.51%)
Cravatex Ltd.
320.10
2.40 (0.76%)
Techknowgreen Solutions Ltd.
109.00
4.00 (3.81%)
Royal Sense Ltd.
139.50
2.50 (1.82%)
Kemistar Corporation Ltd.
67.30
-6.90 (9.30%)
Biogen Pharmachem Industries FAQs
The Buying Price of Biogen Pharmachem Industries share is 0.53 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Biogen Pharmachem Industries stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Biogen Pharmachem Industries, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Biogen Pharmachem Industries shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Biogen Pharmachem Industries shares is 0. Useful to assess the stock's value relative to its book value.
To assess Biogen Pharmachem Industries’s valuation compare Sector P/E, P/B which are 37.56 & 1.89 with sector averages, along with growth rates and financial metrics.
The Market Cap of Biogen Pharmachem Industries is 47.84 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Biogen Pharmachem Industries share price is 1.08 & 0.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Biogen Pharmachem Industries belongs to the Miscellaneous sector.
